ZYME
Overvalued by 212.1% based on the discounted cash flow analysis.
Market cap | $802.22 Million |
---|---|
Enterprise Value | $781.59 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-1617.67 |
Beta | 1.17 |
Outstanding Shares | 75,846,681 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -7.13 |
---|---|
PEG | -0.01 |
Price to Sales | - |
Price to Book Ratio | 2.94 |
Enterprise Value to Revenue | 18.2 |
Enterprise Value to EBIT | -0.01 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | 0.06 |
Debt to Equity | 0.13 |
No data
No data